Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if SNDX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
41 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
243 filers reported a long position in SNDX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $197.2M | 9M | +9.3% |
| Kynam Capital Management, LP | $176M | 8.1M | Unchanged |
| GOLDMAN SACHS GROUP INC | $128.1M | 5.9M | +17.3% |
| STATE STREET CORP | $123.7M | 5.7M | +27.7% |
| BANK OF AMERICA CORP /DE/ | $88.4M | 4M | -4.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | $85.9M | 3.9M | +2.8% |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $82.6M | 3.8M | Unchanged |
| Eversept Partners, LP | $61.2M | 2.8M | -3% |
| GEODE CAPITAL MANAGEMENT, LLC | $56.5M | 2.6M | +19.8% |
| Hood River Capital Management LLC | $56.1M | 2.6M | +8.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.